Indolent & Transformed Lymphoma
Updated: April 2011
The Cancer Management Guidelines for Indolent & Transformed Lymphoma are divided into five sections:
- Diagnosis - information about diagnosis and staging
- Treatment - treatment options, assessment of response, treatment protocols, suggested treatment algorithms
- Outcomes - statistics, results and curves
- Publications - recent related publications
- Clinical Trials - current research studies and clinical trials at the Leukemia/BMT Program of BC
| The information contained in these guidelines is a statement of consensus of Leukemia/BMT Program of BC professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgment in the context of individual clinical circumstances to determine any patient’s care or treatment. Use of these guidelines and documents is at your own risk and is subject to the Leukemia/BMT Program of BC’s terms of use available at Terms of Use. |